San Diego, U.S., Shanghai, China, and Solna, Sweden, August 25, 2021. Inmagene Biopharmaceuticals (“Inmagene”), a leading biotech company focused on […]
San Diego, U.S., Shanghai, China, and Solna, Sweden, February 10, 2021 — Inmagene Biopharmaceuticals (“Inmagene”) and Affibody AB (“Affibody”) today
Hong Kong, Shanghai, San Diego & Florham Park, NJ: Monday, January 11, 2021 — Inmagene Biopharmaceuticals (“Inmagene”) and Hutchison China
Shanghai, China, November 9, 2020 — Inmagene Biopharmaceuticals (“Inmagene”), announced today that it had closed a $21 million Series B
Solna, Sweden & Shanghai, China, May 15, 2020 — Affibody AB (“Affibody”) and Inmagene Biopharmaceuticals (“Inmagene”) today announced a strategic
